keyword
https://read.qxmd.com/read/38636085/polyvalent-aptamer-functionalized-nir-ii-quantum-dots-for-targeted-theranostics-in-high-pd-l1-expressing-tumors
#1
JOURNAL ARTICLE
Xin Huang, Jiawei Zhu, Chuhuang Dong, Yuqing Li, Qing Yu, Xuan Wang, Zhejie Chen, Jiabei Li, Yu Yang, Haifang Wang
Ag2 S quantum dots (QDs) show superior optical properties in the NIR-II region and display significant clinical potential with favorable biocompatibility. However, inherent defects of low targeting and poor solubility necessitate practical modification methods to achieve the theranostics of Ag2 S QDs. Herein, we used rolling circle amplification (RCA) techniques to obtain long single-stranded DNA containing the PD-L1 aptamer and C-rich DNA palindromic sequence. The C-rich DNA palindromic sequences can specifically chelate Ag2+ and thus serve as a template to result in biomimetic mineralization and formation of pApt-Ag2 S QDs...
April 18, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38635899/cd106-in-tumor-specific-exhausted-cd8-t-cells-mediates-immunosuppression-by-inhibiting-tcr-signaling
#2
JOURNAL ARTICLE
Yuto Naoi, Takao Morinaga, Joji Nagasaki, Ryo Ariyasu, Youki Ueda, Kazuo Yamashita, Wenhao Zhou, Shusuke Kawashima, Katsushige Kawase, Akiko Honobe-Tabuchi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yu Kawahara, Yasuhiro Nakamura, Yukiko Kiniwa, Osamu Yamasaki, Satoshi Fukushima, Masahito Kawazu, Yutaka Suzuki, Hiroyoshi Nishikawa, Toyoyuki Hanazawa, Mizuo Ando, Takashi Inozume, Yosuke Togashi
T cell exhaustion is a major contributor to immunosuppression in the tumor microenvironment (TME). Blockade of key regulators of T cell exhaustion, such as PD-1, can reinvigorate tumor-specific T cells and activate anti-tumor immunity in various types of cancer. Here, we identified that CD106 was specifically expressed in exhausted CD8+ T cells in the TME using single-cell RNA-sequencing. High CD106 expression in the TME in clinical samples corresponded to improved response to cancer immunotherapy. CD106 in tumor-specific T cells suppressed anti-tumor immunity both in vitro and in vivo, and loss of CD106 in CD8+ T cells suppressed tumor growth and improved response to PD-1 blockade...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635895/fc-silent-anti-tigit-antibodies-potentiate-anti-tumor-immunity-without-depleting-regulatory-t-cells
#3
JOURNAL ARTICLE
Dana Piovesan, Amber E de Groot, Soonweng Cho, Amy E Anderson, Rebecca D Ray, Amita Patnaik, Paul G Foster, Casey G Mitchell, Alejandra Y Lopez Espinoza, Wandi S Zhu, Carlo E Stagnaro, Hema Singh, Xiaoning Zhao, Lisa Seitz, Nigel P Walker, Matthew J Walters, Kelsey E Sivick
TIGIT is an inhibitory receptor on immune cells that outcompetes an activating receptor, CD226, for shared ligands. Tumor-infiltrating lymphocytes express TIGIT and CD226 on regulatory T cells (Treg) and on CD8+ T cells with tumor-reactive or exhausted phenotypes, supporting the potential of therapeutically targeting TIGIT to enhance anti-tumor immunity. To optimize the efficacy of therapeutic antibodies against TIGIT, it is necessary to understand whether there is therapeutic benefit from Fcγ receptor (FcγR) binding...
April 18, 2024: Cancer Research
https://read.qxmd.com/read/38635321/the-gut-microbe-pair-of-oribacterium-sp-gmb0313-and-ruminococcus-sp-gmb0270-confers-complete-protection-against-sars-cov-2-infection-by-activating-cd8-t-cell-mediated-immunity
#4
JOURNAL ARTICLE
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, Chongkai Zhai, Md Minarul Islam, Hyeon J Kim, Seong-Tshool Hong
Despite the potential protective role of the gut microbiome against COVID-19, specific microbes conferring resistance to COVID-19 have not yet been identified. In this work, we aimed to identify and validate gut microbes at the species level that provide protection against SARS-CoV-2 infection. To identify gut microbes conferring protection against COVID-19, we conducted a fecal microbiota transplantation (FMT) from an individual with no history of COVID-19 infection or immunization into a lethal COVID-19 hamster model...
2024: Gut Microbes
https://read.qxmd.com/read/38634730/omip-102-50-color-phenotyping-of-the-human-immune-system-with-in-depth-assessment-of-t-cells-and-dendritic-cells
#5
JOURNAL ARTICLE
Andrew J Konecny, Peter L Mage, Aaron J Tyznik, Martin Prlic, Florian Mair
We report the development of an optimized 50-color spectral flow cytometry panel designed for the in-depth analysis of the immune system in human blood and tissues, with the goal of maximizing the amount of information that can be collected using currently available flow cytometry platforms. We established and tested this panel using peripheral blood mononuclear cells (PBMCs), but included CD45 to enable its future use for the analysis of human tissue samples. The panel contains lineage markers for all major immune cell subsets, and an extensive set of phenotyping markers focused on the activation and differentiation status of the T cell and dendritic cell (DC) compartment...
April 18, 2024: Cytometry. Part A: the Journal of the International Society for Analytical Cytology
https://read.qxmd.com/read/38634568/using-single-antigen-specificity-magnetic-beads-for-the-isolation-of-specific-antibodies-against-hla-antigens
#6
JOURNAL ARTICLE
Tri T M Vu, Aiwen Zhang, Ronald Wang, Shalu Mathew, Tharindumala Abeywardana, Marissa Beltran-Lemus, Vincent Ma, Mary Libby, Dawn Thomas, Ito Wakefield, Quansheng Zhu, David Lowe, Rui Pei
The presence of multiple donor-specific antibodies (DSAs) targeting HLA antigens poses a challenge to transplantation. Various techniques, including the use of recombinant cell lines and crossmatch cells have been developed to isolate DSAs. To simplify the extraction of HLA-specific DSAs from complex sera, we introduced magnetic beads with single HLA specificity (MagSort). Sera were treated with MagSort, allowing HLA-specific antibodies to bind to the beads, and these specific antibodies were subsequently eluted...
April 2024: HLA
https://read.qxmd.com/read/38634290/a-promising-strategy-of-surface-modified-nanoparticles-targeting-cxcr4-for-precision-cancer-therapy
#7
REVIEW
Khent Primo Alcantara, John Wilfred T Malabanan, Opa Vajragupta, Pornchai Projsitthisak, Pranee Rojsitthisak
Nanoparticle (NP) functionalization with specific ligands enhances targeted cancer therapy and imaging by promoting receptor recognition and improving cellular uptake. This review focuses on recent research exploring the interaction between cancer cell-expressed chemokine receptor 4 (CXCR4) and ligand-conjugated NPs, utilizing small molecules, peptides, and antibodies. Active NP targeting has shown improved tumor targeting and reduced toxicity, enabling precision therapy and diagnosis.However, challenges persist in the clinical translation of targeted NPs due to issues with biological response, tumor accumulation, and maintaining NP quality at an industrial scale...
April 18, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38634209/spatiotemporally-controlled-t-cell-combination-therapy-for-solid-tumor
#8
JOURNAL ARTICLE
Meixi Hao, Ying Zhou, Sijia Chen, Yu Jin, Xiuqi Li, Lingjing Xue, Mingxuan Shen, Weishuo Li, Can Zhang
Due to multidimensional complexity of solid tumor, development of rational T-cell combinations and corresponding formulations is still challenging. Herein, a triple combination of T cells are developed with Indoleamine 2,3-dioxygenase inhibitors (IDOi) and Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i). To maximize synergism, a spatiotemporally controlled T-cell engineering technology to formulate triple drugs into one cell therapeutic, is established. Specifically, a sequentially responsive core-shell nanoparticle (SRN) encapsulating IDOi and CDK4/6i is anchored onto T cells...
April 17, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38633838/microcomputed-tomography-as-a-diagnostic-tool-for-detection-of-lymph-node-metastasis-in-non-small-cell-lung-cancer-a-decision-support-approach-for-pathological-examination-a-pilot-study-for-method-validation
#9
JOURNAL ARTICLE
Ayten Kayı Cangır, Süleyman Gökalp Güneş, Kaan Orhan, Hilal Özakıncı, Yusuf Kahya, Duru Karasoy, Serpil Dizbay Sak
BACKGROUND: Non-small cell lung cancer (NSCLC) patients without lymph node (LN) metastases (pN0) may exhibit different survival rates, even when their T stage is similar. This divergence could be attributed to the current pathology practice, wherein LNs are examined solely in two-dimensional (2D). Unfortunately, adhering to the protocols of 2D pathological examination does not ensure the exhaustive sampling of all excised LNs, thereby leaving room for undetected metastatic foci in the unexplored depths of tissues...
December 2024: Journal of Pathology Informatics
https://read.qxmd.com/read/38633814/deep-learning-modeling-of-rare-noncoding-genetic-variants-in-human-motor-neurons-defines-ccdc146-as-a-therapeutic-target-for-als
#10
Sai Zhang, Tobias Moll, Jasper Rubin-Sigler, Sharon Tu, Shuya Li, Enming Yuan, Menghui Liu, Afreen Butt, Calum Harvey, Sarah Gornall, Elham Alhalthli, Allan Shaw, Cleide Dos Santos Souza, Laura Ferraiuolo, Eran Hornstein, Tatyana Shelkovnikova, Charlotte H van Dijk, Ilia S Timpanaro, Kevin P Kenna, Jianyang Zeng, Philip S Tsao, Pamela J Shaw, Justin K Ichida, Johnathan Cooper-Knock, Michael P Snyder
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable neurodegenerative disease caused by the selective and progressive death of motor neurons (MNs). Understanding the genetic and molecular factors influencing ALS survival is crucial for disease management and therapeutics. In this study, we introduce a deep learning-powered genetic analysis framework to link rare noncoding genetic variants to ALS survival. Using data from human induced pluripotent stem cell (iPSC)-derived MNs, this method prioritizes functional noncoding variants using deep learning, links cis-regulatory elements (CREs) to target genes using epigenomics data, and integrates these data through gene-level burden tests to identify survival-modifying variants, CREs, and genes...
April 1, 2024: medRxiv
https://read.qxmd.com/read/38633624/distinct-roles-of-cd244-expression-in-cancer-diagnosis-and-prognosis-a-pan-cancer-analysis
#11
JOURNAL ARTICLE
Zhenzhen Deng, Yuanhong Liu, Haiyan Zhou
The abnormal expression of tumor associated genes in pan-cancer is closely related to the clinicopathological features of distinct cancer types. Thus, identifying the role of specific genes in pan-cancer is needed for developing effective anti-cancer strategies. However, the function of CD244 in pan-cancer has not been fully understood. In this study, we explored the CD244 expression profile across 33 tumor types based on The Cancer Genome Atlas project, the Gene Expression Omnibus database, and other bioinformatics tools...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38633588/napyradiomycin-b4-suppresses-rankl-induced-osteoclastogenesis-and-prevents-alveolar-bone-destruction-in-experimental-periodontitis
#12
JOURNAL ARTICLE
Ju Ang Kim, Soomin Lim, Geum Jin Kim, Velina Silviani, Jung-Eun Kim, Jong-Sup Bae, Joo-Won Nam, Hyukjae Choi, Eui Kyun Park
The unique structure and beneficial biological properties of marine natural products have drawn interest in drug development. Here, we examined the therapeutic potential of napyradiomycin B4 isolated from marine-derived Streptomyces species for osteoclast-related skeletal diseases. Bone marrow-derived macrophages were treated with napyradiomycin B4 in an osteoclast-inducing medium, and osteoclast formation, osteoclast-specific gene expression, and nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) localization were evaluated using tartrate-resistant acid phosphatase staining, real-time PCR, and immunostaining, respectively...
April 12, 2024: ACS Pharmacology & Translational Science
https://read.qxmd.com/read/38633261/improve-a-feature-model-to-predict-neoepitope-immunogenicity-through-broad-scale-validation-of-t-cell-recognition
#13
JOURNAL ARTICLE
Annie Borch, Ibel Carri, Birkir Reynisson, Heli M Garcia Alvarez, Kamilla K Munk, Alessandro Montemurro, Nikolaj Pagh Kristensen, Siri A Tvingsholm, Jeppe Sejerø Holm, Christina Heeke, Keith Henry Moss, Ulla Kring Hansen, Anna-Lisa Schaap-Johansen, Frederik Otzen Bagger, Vinicius Araujo Barbosa de Lima, Kristoffer S Rohrberg, Samuel A Funt, Marco Donia, Inge Marie Svane, Ulrik Lassen, Carolina Barra, Morten Nielsen, Sine Reker Hadrup
BACKGROUND: Mutation-derived neoantigens are critical targets for tumor rejection in cancer immunotherapy, and better tools for neoepitope identification and prediction are needed to improve neoepitope targeting strategies. Computational tools have enabled the identification of patient-specific neoantigen candidates from sequencing data, but limited data availability has hindered their capacity to predict which of the many neoepitopes will most likely give rise to T cell recognition. METHOD: To address this, we make use of experimentally validated T cell recognition towards 17,500 neoepitope candidates, with 467 being T cell recognized, across 70 cancer patients undergoing immunotherapy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633258/cd8-t-cells-are-necessary-for-improved-sepsis-survival-induced-by-cd28-agonism-in-immunologically-experienced-mice
#14
JOURNAL ARTICLE
Jerome C Anyalebechi, Yini Sun, Carolyn Davis, Maylene E Wagener, Zhe Liang, Eileen M Burd, Craig M Coopersmith, Mandy L Ford
INTRODUCTION: A hallmark of T cell dysregulation during sepsis is the downregulation of costimulatory molecules. CD28 is one of T cell costimulatory molecules significantly altered on memory T cells during sepsis. We recently showed that treatment with a αCD28 agonist in septic immunologically experienced mice led to improved survival. Therefore, here we aimed to identify the cell subset(s) necessary for the survival benefit observed in the context of CD28 agonism, and to further investigate the mechanism by which CD28 agonism improves sepsis survival in immunologically experienced mice...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633256/detecting-t-cell-clonal-expansions-and-quantifying-clone-survival-using-deep-profiling-of-immune-repertoires
#15
JOURNAL ARTICLE
Anastasia V Pavlova, Ivan V Zvyagin, Mikhail Shugay
An individual's T-cell repertoire constantly changes under the influence of external and internal factors. Cells that do not receive a stimulatory signal die, while those that encounter and recognize a pathogen or receive a co-stimulatory signal divide, resulting in clonal expansions. T-cell clones can be traced by monitoring the presence of their unique T-cell receptor (TCR) sequence, which is assembled de novo through a process known as V(D)J rearrangement. Tracking T cells can provide valuable insights into the survival of cells after hematopoietic stem cell transplantation (HSCT) or cancer treatment response and can indicate the induction of protective immunity by vaccination...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38633249/early-b-cell-transcriptomic-markers-of-measles-specific-humoral-immunity-following-a-3-rd-dose-of-mmr-vaccine
#16
JOURNAL ARTICLE
Iana H Haralambieva, Jun Chen, Huy Quang Quach, Tamar Ratishvili, Nathaniel D Warner, Inna G Ovsyannikova, Gregory A Poland, Richard B Kennedy
B cell transcriptomic signatures hold promise for the early prediction of vaccine-induced humoral immunity and vaccine protective efficacy. We performed a longitudinal study in 232 healthy adult participants before/after a 3rd dose of MMR (MMR3) vaccine. We assessed baseline and early transcriptional patterns in purified B cells and their association with measles-specific humoral immunity after MMR vaccination using two analytical methods ("per gene" linear models and joint analysis). Our study identified distinct early transcriptional signatures/genes following MMR3 that were associated with measles-specific neutralizing antibody titer and/or binding antibody titer...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38632998/the-single-d380-amino-acid-substitution-increases-pneumolysin-cytotoxicity-toward-neuronal-cells
#17
JOURNAL ARTICLE
Simona Serra, Vittorio Iannotti, Margherita Ferrante, Miguel Tofiño-Vian, Joseph Baxendale, Gilad Silberberg, Thomas P Kohler, Sven Hammerschmidt, Andrew T Ulijasz, Federico Iovino
Bacterial meningitis, frequently caused by Streptococcus pneumoniae (pneumococcus), represents a substantial global health threat leading to long-term neurological disorders. This study focused on the cholesterol-binding toxin pneumolysin (PLY) released by pneumococci, specifically examining clinical isolates from patients with meningitis and comparing them to the PLY-reference S. pneumoniae strain D39. Clinical isolates exhibit enhanced PLY release, likely due to a significantly higher expression of the autolysin LytA...
April 19, 2024: IScience
https://read.qxmd.com/read/38632993/single-cell-characterization-of-blood-and-expanded-regulatory-t%C3%A2-cells-in-autoimmune-polyendocrine-syndrome-type-1
#18
JOURNAL ARTICLE
Thea Sjøgren, Shahinul Islam, Igor Filippov, Adrianna Jebrzycka, André Sulen, Lars E Breivik, Alexander Hellesen, Anders P Jørgensen, Kari Lima, Liina Tserel, Kai Kisand, Pärt Peterson, Annamari Ranki, Eystein S Husebye, Bergithe E Oftedal, Anette S B Wolff
Immune tolerance fails in autoimmune polyendocrine syndrome type 1 (APS-1) because of AIRE mutations. We have used single cell transcriptomics to characterize regulatory T cells (Tregs) sorted directly from blood and from in vitro expanded Tregs in APS-1 patients compared to healthy controls. We revealed only CD52 and LTB (down) and TXNIP (up) as consistently differentially expressed genes in the datasets. There were furthermore no large differences of the TCR-repertoire of expanded Tregs between the cohorts, but unique patients showed a more restricted use of specific clonotypes...
April 19, 2024: IScience
https://read.qxmd.com/read/38632658/tumor-immune-dysfunction-and-exclusion-subtypes-in-bladder-cancer-and-pan-cancer-a-novel-molecular-subtyping-strategy-and-immunotherapeutic-prediction-model
#19
JOURNAL ARTICLE
Kun Zheng, Youlong Hai, Hongqi Chen, Yukun Zhang, Xiaoyong Hu, Kai Ni
BACKGROUND: Molecular subtyping is expected to enable precise treatment. However, reliable subtyping strategies for clinical application remains defective and controversial. Given the significance of tumor immune dysfunction and exclusion (TIDE), we aimed to develop a novel TIDE-based subtyping strategy to guide personalized immunotherapy in the bladder cancer (BC). METHODS: Transcriptome data of BC was used to evaluate the heterogeneity and the status of TIDE patterns...
April 17, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38632642/spatial-and-single-cell-explorations-uncover-prognostic-significance-and-immunological-functions-of-mitochondrial-calcium-uniporter-in-breast-cancer
#20
JOURNAL ARTICLE
Chia-Jung Li, Yen-Dun Tony Tzeng, Jui-Hu Hsiao, Ling-Ming Tseng, Tzu-Sheng Hsu, Pei-Yi Chu
The mitochondrial calcium uniporter (MCU) is a transmembrane protein facilitating the entry of calcium ions into mitochondria from the cell cytosol. Maintaining calcium balance is crucial for enhancing cellular energy supply and regulating cell death. The interplay of calcium balance through MCU and the sodium-calcium exchanger is known, but its regulation in the breast cancer tumor microenvironment remains elusive. Further investigations are warranted to explore MCU's potential in BRCA clinical pathology, tumor immune microenvironment, and precision oncology...
April 17, 2024: Cancer Cell International
keyword
keyword
44730
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.